Alterity Therapeutics (ATHE) Free Cash Flow (2007 - 2025)
Alterity Therapeutics (ATHE) free cash flow from Jun 30, 2007 to Dec 31, 2025. The TTM Alterity Therapeutics (ATHE) free cash flow is -$21M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Alterity Therapeutics (ATHE) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +14.93% |
| 3 Years TTM | +31.36% |
| 5 Years TTM | +2.71% |
| All Time TTM | +1.04% |
Annual Free Cash Flow change of Alterity Therapeutics (ATHE)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$15M | +84.12% |
| 2024 | -$8.40M | -37.08% |
| 2023 | -$13M | +55.68% |
| 2022 | -$8.58M | -34.03% |
| 2021 | -$13M | +99.38% |
| 2020 | -$6.52M | -32.94% |
| 2019 | -$9.72M | +110.00% |
| 2018 | -$4.63M | +2.11% |
| 2017 | -$4.53M | -17.95% |
| 2016 | -$5.53M | -34.08% |
| 2015 | -$8.38M | -35.62% |
| 2014 | -$13M | +76.97% |
| 2013 | -$7.36M | +4.32% |
| 2012 | -$7.05M | +44.14% |
| 2011 | -$4.89M | +23.09% |
| 2010 | -$3.98M | -29.76% |
| 2009 | -$5.66M | -37.55% |
| 2008 | -$9.06M | +14.77% |
| 2007 | -$7.90M | N/A |
Comparison Alterity Therapeutics (ATHE) five years free cash flow CAGR with competitors
Alterity Therapeutics (ATHE) five years free cash flow CAGR is 19.72%.